Massage for Prostate Cancer-Related Fatigue, mPROSTATE Study

Eligibility Criteria

• * Male subjects aged \>= 45 years old
• * Histologically confirmed diagnosis of prostate cancer
• * Subjects must have completed radiation therapy \>= 2 months, prior to registration
• * Subjects undergoing androgen depravation therapy with serum testosterone levels \< 20 ng/ml
• * Subjects who have a score \> 25 on the Brief Fatigue Inventory (BFI) at screening
• * Subjects who are fluent in speaking and reading English
• * Based on International Classification of Diseases (ICD)-10 proposed criteria, the patient must have a diagnosis of CRF with evidence from the history, physical exam, and laboratory findings that the fatigue is a consequence of cancer or cancer therapy and not primarily a consequence of any of the following:
• * Comorbid psychiatric disorders
• * Anemia (hemoglobin less than 10 g/dl)
• * Hypothyroidism (thyroid stimulating hormone (TSH) greater than 4.6 micro-international units (uIU)/mL)
• * Uncontrolled pain
• * Any medical or psychiatric condition or medication felt to be clinically contributing to fatigue based on the investigator's history, physical examination, and assessment. These medical circumstances may include:
• * The use of medications such as opioids, sedating anti-histamines, or neuroleptics;
• * Medical problems associated with fatigue: chronic obstructive pulmonary disease, congestive heart failure, renal disease, hepatic dysfunction, uncontrolled autoimmune disease, neurological disorders such as multiple sclerosis or Parkinson's disease, and sleep apnea
• * Able to provide informed consent and willing to sign an approved consent form that conforms to federal and institutional guidelines
• * Inability to lay supine for one hour at a time, given the nature of the massage intervention
• * Body-mass index less than 18.5 (kg/m\^2)
• * Current use of any medications or therapies listed as prohibited in Section 6.6.1.
• * Treatment with corticosteroids or other immunosuppressants =\< 6 months prior to registration, , unless the medication is necessary to support patient wellbeing and unlikely to negatively impact study aims, per PI judgement..
• * Subjects who cannot comply with the protocol for any reason
• * Regular use of anti-inflammatory drugs including non-steroidal anti-inflammatory drugs and natural products thought to have anti-inflammatory properties, unless the medication is necessary to support patient wellbeing and unlikely to negatively impact study aims, per PI judgement..
• * Change in prescribed dose of medications for anxiety or depression =\< 4 weeks prior to registration.
• * Change in fluoxetine dose within =\< 8 weeks prior to registration
• * Subjects meeting criteria for a current substance use diagnosis or current diagnoses of schizophrenia, depression, generalized anxiety disorder, bipolar disorder, dementia, delirium, or obsessive compulsive disorder (OCD)
• * Subjects who are actively suicidal or homicidal
• * Other conditions or behaviors that, in the opinion of the treating investigator, may negatively impact study participation, including the following:
• * Illicit drug use
• * Shift work
• * Current dieting
• * Excessive regular use of alcohol (more than two 5-ounce glasses of wine or equivalents/day)
• * Any instance of binge drinking (more than 7 drinks in a 24-hour period) =\< 6 months prior to registration
• * Current and/or past use of massage for the treatment of fatigue.
• * Medical, psychiatric, cognitive, or other conditions that may compromise the subject's ability to understand the subject information, give informed consent, comply with the study protocol, or complete the study